Fig. 2From: Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trialNodular area at baseline and Week 8. Error bars represent standard deviations. * P ≤ 0.0003 vs placebo. CCH, collagenase clostridium histolyticumBack to article page